What is the main business of Pharmitis?

The main business activity of Pharmitis focuses on wholesale of other intermediate products.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on April 29, 2025.

Where is the headquarters located?

The headquarters is located at: ul. Leśna 20, 85-676 Bydgoszcz.

Who is on the management board?

The management board consists of: Andrzej Marek Winnicki (Member of the Management Board) and Tomasz Gnatowski (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 105,000 (approx. $28,363).

What period do the latest financial data cover?

The latest available financial statement covers the period from April 14, 2025 to December 31, 2025.

What revenue was generated?

In 2025, the company generated total revenue of USD 301.

Is the company profitable?

No, in 2025 the company was not profitable, reporting a net loss of USD 32,040.

Which cost dominates operating expenses?

The largest operating cost category falls under materials and energy. This category amounted to USD 24,816 in 2025, representing 77% of all operating expenses.

Pharmitissp. z o.o.

Wholesale of other intermediate products

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2025-04-29

Share capital

105 000,00 PLN

Activity description

Pharmitis Sp. z o.o. supplies raw materials for modern pharmacy and supports pharmacies with compounding services. The company is based at 20/71 Lesna Street in Bydgoszcz, Poland.

Registered address

ul. Leśna 20/71, 85-676 Bydgoszcz, Poland

Website

pharmitis.com

Electronic delivery address

AE:PL-71405-82636-SVEDE-27

Financials

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 301.36MedianUSD 1.10mAverageUSD 11.41m

Net profit

This companyUSD -32.04kMedianUSD 13.28kAverageUSD 546.60k

Operating costs

This companyUSD 32.34kMedianUSD 988.80kAverageUSD 10.56m

Assets

This companyUSD 9.11kMedianUSD 567.21kAverageUSD 6.69m

Industry

Bank accounts

Registered as a VAT taxpayer on 2025-05-13. Active

PKO Bank Polski
59 1020 1475 0000 8102 0426 0899

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Trademarks

Pharmitis currently holds no active trademarks with the Polish Patent Office. 2 applications are pending. The first mark was filed in 2025.

Mark	Number	Classes	Status	Protected until
Pharmitis(word)	Z.585494	5, 35, 42	Application pending	–
RP RECEPTARIUM POLONICUM	Z.585495	9, 35, 41, 42	Application pending	–

Mark	Protected until
Pharmitis(word)	–
RP RECEPTARIUM POLONICUM	–

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Authorized Representatives

Andrzej Marek Winnicki – Management Board Member

Tomasz Gnatowski – President of the Management Board

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
Tomasz Gnatowski (39)	350	$9,454.35	33.3333%
Andrzej Marek Winnicki (40)	350	$9,454.35	33.3333%
Anna Maria Witkowska (54)	350	$9,454.35	33.3333%

Beneficial owners

Person	Rights

Competitors

	Name	Revenue	Website
	Biomental Farmasp. z o.o.	$501.13	biomental-farma.com
	PharmenaS.A.	$396.03	pharmena.eu

FAQ

Last updated: 2026-08-20